Celcuity (CELC) Non-Current Debt (2021 - 2025)
Celcuity (CELC) reported Non-Current Debt of $126.5 million for Q4 2025, up 29.47% on a YoY basis from $97.7 million in Q4 2024, and up 1.09% quarter-over-quarter from $125.2 million in Q3 2025.
Celcuity (CELC) Non-Current Debt (2021 - 2025) Analysis & Trends
Celcuity has reported Non-Current Debt for 5 years, with the latest figure at $126.5 million in Q4 2025.
- For the quarter ending Q4 2025, Non-Current Debt rose 29.47% year-over-year to $126.5 million; the trailing twelve-month figure through Dec 2025 stood at $126.5 million (up 29.47% YoY), and the FY2025 full-year result was $126.5 million, up 29.47% from the prior year.
- Non-Current Debt for Q4 2025 stood at $126.5 million, up from $125.2 million in the prior quarter.
- The five-year high for Non-Current Debt was $126.5 million in Q4 2025, with the low at $14.2 million in Q2 2021.
- Historically, Non-Current Debt has averaged $55.1 million across 5 years, with a median of $36.5 million in 2023.
- Annual changes were most pronounced in 2024 — Non-Current Debt surged 167.31% — and 2025, when it advanced 3.2%.
- Celcuity's Non-Current Debt stood at $14.6 million in 2021, then jumped by 139.19% to $35.0 million in 2022, then increased by 5.87% to $37.0 million in 2023, then soared by 163.87% to $97.7 million in 2024, then increased by 29.47% to $126.5 million in 2025.
- The last three Non-Current Debt figures came in at $126.5 million (Q4 2025), $125.2 million (Q3 2025), and $99.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 319.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Celcuity | 4.14 Bn | 3.42 Bn | - | 126.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 126.53 Mn |
| Dec 31, 2025 | 126.53 Mn |
| Sep 30, 2025 | 125.17 Mn |
| Sep 30, 2025 | 125.17 Mn |
| Jun 30, 2025 | 99.28 Mn |
| Jun 30, 2025 | 99.28 Mn |
| Mar 31, 2025 | 98.53 Mn |
| Mar 31, 2025 | 98.53 Mn |
| Dec 31, 2024 | 97.73 Mn |
| Dec 31, 2024 | 97.73 Mn |
| Sep 30, 2024 | 96.92 Mn |
| Sep 30, 2024 | 96.92 Mn |
| Jun 30, 2024 | 96.19 Mn |
| Jun 30, 2024 | 96.19 Mn |
| Mar 31, 2024 | 37.57 Mn |
| Mar 31, 2024 | 37.57 Mn |
| Dec 31, 2023 | 37.04 Mn |
| Dec 31, 2023 | 37.04 Mn |
| Sep 30, 2023 | 36.51 Mn |
| Sep 30, 2023 | 36.51 Mn |